75 citations
,
September 1971 in “British Journal of Dermatology” This study found that both intralesional triamcinolone acetonide and triamcinolone hexacetonide promote continuous hair growth in alopecia areata, with effects lasting at least 9 months after a single injection.
February 2025 in “Revista Eletrônica Acervo Saúde” This integrative review found that triamcinolone hexacetonide remains the primary treatment for mild to moderate alopecia areata but noted its significant side effects with prolonged use, while emerging therapies like PRP and minoxidil offer promising alternative benefits with fewer risks.
11 citations
,
January 2017 in “Skin Appendage Disorders” This study associated ivory-colored areas observed through trichoscopy with steroid deposits in the dermis among patients with steroid-induced atrophy on the scalp.
January 2022 in “Skin Appendage Disorders” This case report describes areata-like lupus in a 63-year-old woman, characterized by nonscarring patchy alopecia similar to alopecia areata, without meeting systemic lupus erythematosus criteria.